Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort studySalim Yusuf, Gilles R. Dagenais, Rajeev Gupta et al.|The Lancet|2019Cited by 2k
Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income CountriesSalim Yusuf, Gilles R. Dagenais, Sumathy Rangarajan et al.|New England Journal of Medicine|2014Cited by 993
Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) studyAnnika Rosengren, Salim Yusuf, Andrew Smyth et al.|The Lancet Global Health|2019Cited by 642
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Salim Yusuf, Gholamreza Roshandel et al.|The Lancet|2021Cited by 148